Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ISEC Healthcare is a Singapore-listed regional ophthalmology services company focused on specialist medical eye care rather than drug development. The group operates ambulatory surgical centres and eye clinics across Malaysia, Singapore, and Myanmar, providing services in cataract and refractive surgery, vitreoretinal disease, corneal disease, glaucoma, uveitis, oculoplastics, facial aesthetics, and paediatric ophthalmology. The company uses advanced ophthalmic equipment and facilities and also participates in clinical research and pharmaceutical-sponsored trials through its specialist doctors. ISEC Healthcare has expanded through acquisitions of eye care centres and clinics and is now a subsidiary of Aier Eye International (Singapore), itself part of Aier Eye Hospital Group. Overall, it is best characterized as a commercial specialty eye-care delivery platform rather than a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ISEC.